This article is the 14th in a new series entitled “Educate in order to Medicate”, a campaign UtahCARE - Cannabis Awareness, Respect and Education - will be launching after the first of the year by sending such articles to every Utah lawmaker.
Grassroots organizations such as UtahCARE have be sending such messages for the past 5 years in order to educate Utah representatives and move toward the legalization of cannabis throughout the state.
The State of New Hampshire approved House Bill 573 on May 23, 2013 by the Senate (18-6) and June 26, 2013 by the House (284-66). The bill was signed into law and became effective on July 23, 2013 upon signature by Governor Maggie Hassan.
The bill authorizes the use of therapeutic cannabis in New Hampshire, establishes a registry identification card system, allows for the registration of up to four non-profit alternative treatment centers in the state, and establishes an affirmative defense for qualified patients and designated caregivers with valid registry ID cards.
House Bill 573 also called for the creation of a “Therapeutic Use of Cannabis Advisory Council”, which in five years will be required to "issue a formal opinion on whether the program should be continued or repealed."
A valid ID card from another medical marijuana state will be recognized as allowing the visiting patient to possess cannabis for therapeutic purposes, but the
"visiting qualifying patient shall not cultivate or purchase cannabis in New Hampshire or obtain cannabis from alternative treatment centers..."
New Hampshire approved the following conditions for treatment with medical marijuana: cancer, glaucoma, positive status for HIV, AIDS, hepatitis C, ALS, muscular dystrophy, Crohn's disease, agitation of Alzheimer's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, or
"one or more injuries that significantly interferes with daily activities as documented by the patient's provider; and a severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy induced anorexia, wasting syndrome, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms."
"A qualifying patient shall not obtain more than 2 ounces of usable cannabis directly or through the qualifying patient's designated caregiver during a 10-day period."
A patient may possess two ounces of usable cannabis and any amount of unusable cannabis.
Making information such as this easily available to Utah lawmakers by sending them frequent e-mail blasts is one way in which UtahCARE is working to forward the movement to legalize cannabis throughout the state.
If you enjoyed this article and would like to have similar ones delivered directly to your in-box, simply click subscribe.